Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form

Table 2

Evaluation data of robustness study.

Robust conditions	% Assay	System suitability parameters
		Theoretical plates	Asymmetry
Flow 0.9 mL/min.	100.31	3448	1.03
Flow 1.1 mL/min.	99.76	3372	0.98
Buffer-ACN; (34 : 66, v/v)	99.77	3397	1.02
Buffer-ACN; (30 : 70, v/v)	99.76	3362	1.07
Column change	100.37	3290	1.03